Erratum: Novel analgesic/anti-inflammatory agents: 1,5-Diarylpyrrole nitrooxyalkyl ethers and related compounds as cyclooxygenase-2 inhibiting nitric oxide donors (Journal of Medicinal Chemistry (2013) 56 (3191-3206) DOI: 10.1021/jm301370e);Novel analgesic/anti-inflammatory agents: 1,5-Diarylpyrrole nitrooxyalkyl ethers and related compounds as cyclooxygenase-2 inhibiting nitric oxide donors

Journal of Medicinal Chemistry

Volumn 56, Issue 8, 2013, Pages 3191-3206

  Anzini, Maurizio ^a   Di Capua, Angela ^a   Valenti, Salvatore ^a   Brogi, Simone ^a   Rovini, Michele ^a   Giuliani, Germano ^a   Cappelli, Andrea ^a   Vomero, Salvatore ^a   Chiasserini, Luisa ^a   Sega, Alessandro ^a   Poce, Giovanna ^b   Giorgi, Gianluca ^a   Calderone, Vincenzo ^c   Martelli, Alma ^c   Testai, Lara ^c   Sautebin, Lidia ^d   Rossi, Antonietta ^d   Pace, Simona ^d   Ghelardini, Carla ^e   Di Cesare Mannelli, Lorenzo ^e   Benetti, Veronica ^f   Giordani, Antonio ^g   Anzellotti, Paola ^h   Dovizio, Melania ^h   Patrignani, Paola ^h   Biava, Mariangela ^b   more..

^a UNIVERSITY OF SIENA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF PISA   (Italy)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^e UNIVERSITY OF FLORENCE   (Italy)

^f Innovative Biotech   (Italy)

^g Rotta Research Laboratorium   (Italy)

^h UNIVERSITY OF CHIETI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTIINFLAMMATORY AGENT; CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; GLYCOSAMINOGLYCAN; INTERLEUKIN 1BETA;

ANIMAL CELL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTINOCICEPTION; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CARTILAGE; CONCENTRATION RESPONSE; CONTROLLED STUDY; COW; DRUG CONFORMATION; DRUG EFFICACY; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; DYNAMICS; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE; MALE; MOLECULAR MODEL; MOUSE; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; RAT; SIMULATION; VASODILATATION;

EID: 84876827778     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm400748x     Document Type: Erratum

References (71)

1. Zhang, W.; Moskowitz, R. W.; Nuki, G.; Abramson, S.; Altman, R. D.; Arden, N.; Bierma-Zeinstra, S.; Brandt, K. D.; Croft, P.; Doherty, M.; Dougados, M.; Hochberg, M.; Hunter, D. J.; Kwoh, K.; Lohmander, L. S.; Tugwell, P. OARSI Recommendations for the Management of Hip and Knee Osteoarthritis, Part I: Critical Appraisal of Existing Treatment Guidelines and Systematic Review of Current Research Evidence Osteoarthritis Cartilage 2007, 15, 981-1000
2. Davies, N. M.; Anderson, K. E. Clinical Pharmacokinetics of Diclofenac. Therapeutic Insights and Pitfalls Clin. Pharmacokinet. 1997, 33, 184-213
3. Ricciotti, E.; FitzGerald, G. A. Prostaglandins and Inflammation Arterioscler., Thromb., Vasc. Biol. 2011, 31, 986-1000
4. FitzgGerald, G. A.; Patrono, C. The Coxibs, Selective Inhibitors of Cyclooxygenase-2 N. Engl. J. Med. 2001, 345, 433-442
5. Lanas, A. A Review of the Gastrointestinal Safety Data: A Gastroenterologist's Perspective Rheumatology 2010, 49 (S2) 3-10
6. Antman, E. M.; DeMets, D.; Loscalzo, J. Cyclooxygenase Inhibition and Cardiovascular Risk Circulation 2005, 112, 759-70
7. Di Francesco, L.; Totani, L.; Dovizio, M.; Piccoli, A.; Di Francesco, A.; Salvatore, T.; Pandolfi, A.; Evangelista, V.; Dercho, R. A.; Seta, F.; Patrignani, P. Induction of Prostacyclin by Steady Laminar Shear Stress Suppresses Tumor Necrosis Factor-alpha Biosynthesis via Heme Oxygenase-1 in Human Endothelial Cells Circ. Res. 2009, 104, 506-513
8. Yu, Y.; Ricciotti, E.; Scalia, R.; Tang, S. Y.; Grant, G.; Yu, Z.; Landesberg, G.; Crichton, I.; Wu, W.; Puré, E.; Funk, C. D.; FitzGerald, G. A. Vascular COX-2 Modulates Blood Pressure and Thrombosis in Mice Sci. Transl. Med. 2012, 4, 132ra54
9. Gewaltig, M. T.; Kojda, G. Vasoprotection by Nitric Oxide: Mechanisms and Therapeutic Potential Cardiovasc. Res. 2002, 55, 250-260
10. Grosser, T.; Fries, S.; FitzGerald, G. A. Biological Basis for the Cardiovascular Consequences of COX-2 Inhibition: Therapeutic Challenges and Opportunities J. Clin. Invest. 2006, 116, 4-15
11. Wallace, J. L.; Miller, M. J. Nitric Oxide in Mucosal Defence: A Little Goes a Long Way Gastroenterology 2000, 119, 512-520
12. Whittle, J. R. Cicloxygenase and Nitric Oxide Systems in the Gut as Therapeutic Targets for Safer Anti-Inflammatory Drugs Curr. Opin. Pharmacol. 2004, 4, 538-545
13. Muscará, M. N.; Wallace, J. L. COX-Inhibiting Nitric Oxide Donors (CINODs): Potential Benefits on Cardiovascular and Renal Function Cardiovasc. Hematol. Agents Med. Chem 2006, 4, 155-164
14. Geusens, P. Naproxcinod, a New Cyclooxygenase-Inhibiting Nitric Oxide Donator (CINOD) Expert Opin. Biol. Ther. 2009, 9, 649-657
15. White, W. B.; Schnitzer, T. J.; Fleming, R.; Duquesroix, B.; Beekman, M. Effects of the Cyclooxygenase Inhibiting Nitric Oxide Donator Naproxcinod versus Naproxen on Systemic Blood Pressure in Patients with Osetoarthritis Am. J. Cardiol. 2009, 104, 840-845
16. Weber, M. A. Treatment of Patients with Hypertension and Arthritis Pain: New Concepts Am. J. Med. 2009, 122, S16-S22
17. Govoni, M.; Casagrande, S.; Maucci, R.; Chiroli, V.; Tocchetti, P. In Vitro Metabolism of (Nitroxy)butyl Ester Nitric Oxide-Releasing Compounds: Comparison with Glyceryl Trinitrate J. Pharmacol. Exp. Ther. 2006, 317, 752-776
18. Berndt, G.; Grosser, N.; Hoogstraate, J.; Schröder, H. A Common Pathway of Nitric Oxide Release from AZD3582 and Glyceryl Trinitrate Eur. J. Pharm. Sci. 2004, 21, 331-335
19. Capone, M. L.; Tacconelli, S.; Sciulli, M. G.; Anzellotti, P.; Di Francesco, L.; Merciaro, G.; Di Gregorio, P.; Patrignani, P. Human Pharmacology of Naproxen Sodium J. Pharmacol. Exp. Ther. 2007, 322, 453-460
20. Cappelli, A.; Anzini, M.; Biava, M.; Makovec, F.; Giordani, A.; Caselli, G.; Rovati, L. C. 3-Substituted-1,5-Diaryl-2-alkyl-pyrroles Highly Selective and Orally Effective COX-2 Inhibitors. PCT Int. Appl. WO2008014821, 2008.
21. Anzini, M.; Rovini, M.; Cappelli, A.; Vomero, S.; Manetti, F.; Botta, M.; Sautebin, L.; Rossi, A.; Ghelardini, C.; Norcini, M.; Giordani, A.; Makovec, F.; Anzellotti, P.; Patrignani, P.; Biava, M. Synthesis, Biological Evaluation, and Enzyme Docking Simulations of 1,5-Diarylpyrrole-3-alkoxyethyl Ethers as Highly Selective COX-2 Inhibitors Endowed with Anti-Inflammatory and Antinociceptive Activity J. Med. Chem. 2008, 51, 4476-4481
22. Biava, M.; Porretta, G. C.; Poce, G.; Battilocchio, C.; Manetti, F.; Botta, M.; Forli, S.; Sautebin, L.; Rossi, A.; Pergola, C.; Ghelardini, C.; Galeotti, N.; Makovec, F.; Giordani, A.; Anzellotti, P.; Patrignani, P.; Anzini, M. Novel Ester and Acid Derivatives of the 1,5-Diarylpyrrole Scaffold as Anti-Inflammatory and Analgesic Agents. Synthesis and in Vitro and in Vivo Biological Evaluation J. Med. Chem. 2010, 53, 723-733 and references cited therein
23. Giordani, A.; Biava, M.; Anzini, M.; Calderone, V.; Rovati, L. 1,5-Diaryl-2-alkyl-pyrrole-3-Substituted Nitro Esters Selective COX-2 Inhibitors and Nitric Oxide Donors. WO2012032479 A1, 2012.
24. Biava, M.; Porretta, G. C.; Poce, G.; Battilocchio, C.; Salvatore Alfonso, S.; Rovini, M.; Valenti, S.; Giorgi, G.; Calderone, V.; Martelli, A.; Testai, L.; Sautebin, L.; Rossi, A.; Papa, G.; Ghelardini, C.; Di Cesare Mannelli, L.; Giordani, A.; Anzellotti, P.; Patrignani, P.; Anzini, M. Novel Analgesic/Anti-Inflammatory Agents: Diarylpyrrole Acetic Esters Endowed with Nitric Oxide Releasing Properties J. Med. Chem. 2011, 54, 7759-7771
25. Martelli, A.; Breschi, M. C.; Calderone, V. Pharmacodynamic Hybrids Coupling Established Mechanisms of Action with Additional Nitric Oxide Releasing Properties Curr. Pharm. Des. 2009, 15, 614-636
26. Pomonis, J. D.; Boulet, J. M.; Gottshall, S. L.; Phillips, S.; Sellers, R.; Bunton, T.; Walker, K. Development and Pharmacological Characterization of a Rat Model of Osteoarthritis Pain Pain 2005, 114, 339-346
27. Kobayashi, K.; Imaizumi, R.; Sumichika, H.; Tanaka, H.; Goda, M.; Fukunari, A.; Komatsu, H. Sodium Iodoacetate-Induced Experimental Osteoarthritis and Associated Pain Model in Rats J. Vet. Med. Sci. 2003, 65, 1195-1199
28. Pfernihough, J.; Gentry, C.; Malcangio, M.; Fox, A.; Rediske, J.; Pellas, T.; Kidd, B.; Bevan, S.; Winter, J. Pain Related Behaviour in Two Models of Osteoarthritis in the Rat Knee Pain 2004, 112, 83-93
29. Guingamp, C.; Gegout-Pottie, P.; Philippe, L.; Terlain, B.; Netter, P.; Gillet, P. Mono-Iodoacetate-Induced Experimental Osteoarthritis. A Dose-Response Study of Loss of Mobility, Morphology, and Biochemistry Arthritis Rheum. 1997, 40, 1670-1679
30. Janusz, M. J.; Hookfin, E. B.; Heitmeyer, S. A.; Woessner, J. F.; Freemont, A. J.; Hoyland, J. A.; Brown, K. K.; Hsieh, L. C.; Almstead, N. G.; De, B.; Natchus, M. G.; Pikul, S.; Taiwo, Y. O. Moderation of Iodoacetate-Induced Experimental Osteoarthritis in Rats by Matrix Metalloproteinase Inhibitors Osteoarthritis Cartilage 2001, 9, 751-760
31. Wey, S.; Augustyniak, M. E.; Cochran, E. D.; Ellis, J. L.; Fang, X.; Garvey, D. S.; Janero, D. R.; Letts, L. G.; Martino, A. M.; Melim, T. L.; Murty, M. G.; Richardson, S. K.; Schroeder, J. D.; Selig, W. M.; Trocha, A. M.; Wexler, R. S.; Young, D. V.; Zemtseva, I. S.; Zifcak, B. M. Structure-Based Design, Synthesis, and Biological Evaluation of Indomethacin Derivatives as Cyclooxygenase-2 Inhibiting Nitric Oxide Donors J. Med. Chem. 2007, 50, 6367-6382
32. 2 in Articular Cartilage Explants Osteoarthritis Cartilage 2005, 13, 387-394
33. Mort, J. S.; Roughley, P. J. Measurament of Glycosaminoglycan Release from Cartilage Explants Methods Med. 2007, 135, 201-209
34. Homandberg, G. A.; Meyers, R.; Xie, D. I. Fibronectin Fragments Cause Chondrolysis of Bovine Articular Cartilage Slices in Culture J. Biol. Chem. 1992, 25, 3597-3604
35. Farndale, R. W.; Buttle, D. J.; Barret, A. J. Improved Quantitation and Discrimination of Sulphated Glycosaminoglycans by Use of Dimethylmethylene Blue Biochim. Biophys. Acta 1986, 883, 173-177
36. Patrignani, P.; Muramatsu, M.; Tanaka, M.; Fujita, A.; Otomo, S.; Aihara, H. Time-Dependent Inhibition of Prostaglandins Synthesis by Nonsteroidal Antiinflammatory Drugs; Time-Dependent Alteration of Inhibitory Effect and Characteristics of its Active Site Jpn J. Pharmacol. 1984, 35, 37-46
37. Huntjens, D. R; Danhof, M.; Della Pasqua, O. E. Pharmacokinetic- Pharmacodynamic Correlations and Biomarkers in the Development of COX-2 Inhibitors Rheumatology (Oxford, U. K.) 2005, 44, 846-859
38. Baerwald, C.; Verdecchia, P.; Duquesroix, B.; Frayssinet, H.; Ferreira, T. Efficacy, Safety, and Effects on Blood Pressure of Naproxcinod 750 mg Twice Daily Compared with Placebo and Naproxen 500 mg Twice Daily in Patients with Osteoarthritis of the Hip: A Randomized, Double-Blind, Parallel-Group, Multicenter Study Arthritis Rheum. 2010, 62 (12) 3635-3644
39. Abramson, S. B. Nitric Oxide in Inflammation and Pain Associated with Osteoarthritis Arthritis Res. Ther. 2008, 10 (Suppl. 2) S2
40. Krebs, S. A Review on the Derivation of the Spin-Restricted Hartree-Fock (RHF) Self-Consistent Field (SCF) Equations for Open-Shell Systems. Description of Different Methods to Handle the Off-Diagonal Lagrangian Multipliers Coupling Closed and Open Shells Comput. Phys. Commun. 1999, 116, 137-277
41. Yuanpeng, J. H.; Tejero, R.; Powers, R.; Montelione, G. T. A Topology-Constrained Distance Network Algorithm for Protein Structure Determination from NOESY Data Proteins 2006, 62, 587-603
42. Morris, G. M.; Huey, R.; Lindstrom, W.; Sanner, M. F.; Belew, R. K.; Goodsell, D. S.; Olson, A. J. Autodock4 and AutoDockTools4: Automated Docking with Selective Receptor Flexiblity J. Comput. Chem. 2009, 16, 2785-2791
43. Werlhi, F. W. In Topics in Carbon-13 NMR Spectroscopy; Levy, G. C., Ed.; Wiley: New York, 1976; Vol. 2, p 343.
44. Lyerla, J. R., Jr.; Levy, G. C. In Topics in Carbon-13 NMR Spectroscopy; Levy, G. C.; Wiley: New York, 1974; Vol. 1, p 74.
45. Allerhand, A.; Doddrell, D.; Komoroski, R. Natural Abundance Carbon-13 Partially Relaxed Fourier Transform Nuclear Magnetic Resonance Spectra of Complex Molecules J. Chem. Phys. 1971, 55, 189-198
46. Werlhi, F. W.; Wirthlin, T. Interpretation of Carbon-13 NMR Spectra; Heyden: London, 1980.
47. Frey, M. N.; Koetzle, T. F.; Lehmann, M. S.; Hamilton, W. C. Precision Neutron Diffraction Structure Determination of Protein and Nucleic Acid Components. X. A Comparison Between the Crystal and Molecular Structures of l -Tyrosine and l -Tyrosine Hydrochloride J. Chem. Phys. 1973, 58, 2547-2556
48. Noggle, J. H.; Shirmer, R. E. The Nuclear Overhauser Effect; Academic Press: New York, 1971.
49. Neuhaus, D.; Williamson, M. The Nuclear Overhauser Effect in Structural and Conformational Analysis; VCH Publishers, Inc.: New York, 1989.
50. Valensin, G.; Pogliani, L.; Ghelardoni, M.; Pestellini, V.; Sega, A. Nuclear Magnetic Resonance Study of Conformation and Dynamics in Solution of p -(o -Propyloxybenzamido)benzoate Diethyl(2-hydroxyethyl)methylammonium Bromide: A Smooth Muscle Relaxant Agent Can. J. Chem. 1984, 62, 2131-2135
51. Rossi, A.; Ligresti, A.; Longo, R.; Russo, A.; Borrelli, F.; Sautebin, L. The Inhibitory Effect of Propolis and Caffeic Acid Phenethyl Ester on Cyclooxygenase Activity in J774 Macrophages Phytomedicine 2002, 9, 530-535
52. Breschi, M. C.; Calderone, V.; Digiacomo, M.; Martelli, A.; Martinotti, E.; Minutolo, F.; Rapposelli, S.; Balsamo, A. NO-Sartans: A New Class of Pharmacodynamic Hybrids as Cardiovascular Drugs J. Med. Chem. 2004, 47, 5597-5600
53. Patrignani, P.; Panara, M. R.; Greco, A.; Fusco, O.; Natoli, C.; Iacobelli, S.; Cipollone, F.; Ganci, A.; Creminon, C.; Maclouf, J.; Patrono, C. Biochemical and Pharmacological Characterization of the Cyclooxygenase Activity of Human Blood Prostaglandin Endoperoxide Synthases J. Pharmacol. Exp. Ther. 1994, 271, 1705-1712
54. Patrono, C.; Ciabattoni, G.; Pinca, E.; Pugliese, F.; Castrucci, G.; De Salvo, A.; Satta, M. A.; Peskar, B. A. Low Dose Aspirin and Inhibition of Thromboxane B2 Production in Healthy Subjects Thromb. Res. 1980, 17, 317-327
55. Leighton, G. E.; Rodriguez, R. E.; Hill, R. G.; Hughes, J. κ-Opioid Agonists Produce Antinociception after iv and icv but Not Intrathecal Administration in the Rat Br. J. Pharmacol. 1988, 93, 553-560
56. Koster, R.; Anderson, M.; de Beer, E. J. Acetic Acid for Analgesic Screening Fed. Proc. 1959, 18, 412-418
57. Black, G. D.; Schuchardt, K. L.; Gracio, D. K.; Palmer, B. The Extensible Computational Chemistry Environment: A Problem Solving Environment for High Performance Theoretical Chemistry. Computational Science-ICCS 2003, Proceedings 2660 of the International Conference Saint Petersburg Russian Federation, Melbourne, Australia; Sloot, P. M. A.; Abramson, D.; Bogdanov, A. V.; Dongarra, J., Eds.; Springer Verlag: Berlin, 2003; Vol. 81, pp 122-131.
58. Valiev, M.; Bylaska, E. J.; Govind, N.; Kowalski, K.; Straatsma, T. P.; van Dam, H. J. J.; Wang, D.; Nieplocha, J.; Apra, E.; Windus, T. L.; de Jong, W. A. NWChem: A Comprehensive and Scalable Open-Source Solution for Large Scale Molecular Simulations Comput. Phys. Commun. 2010, 181, 1477-1489
59. Khandelwal, A.; Lukacova, V.; Comez, D.; Kroll, D. M.; Raha, S.; Balaz, S. A. Combination of Docking, QM/MM Methods, and MD Simulation for Binding Affinity Estimation J. Med. Chem. 2005, 48, 5437-5447
60. Maestro, version 9.2; Schrödinger, LLC: New York, NY, 2011.
61. Schrodinger. Docs & Known Issues. Protein Preparation Wizard 2011. http://www.schrodinger.com/supportdocs/18/16.
62. Desmond Molecular Dynamics System, version 3.0; Shaw Research: New York, NY, 2011.
63. Maestro-Desmond Interoperability Tools, version 3.0; Schrodinger: New York, NY, 2011.
64. Bowers, K. J.; Chow, E.; Xu, H.; Dror, R. O.; Eastwood, M. P.; Gregersen, B. A.; Klepeis, J. L.; Kolossvary, I.; Moraes, M. A.; Sacerdoti, F. D.; Salmon, J. K.; Shan, Y.; Shaw, D. E. Scalable Algorithms for Molecular Dynamics Simulations on Commodity Clusters. SC '06, Proceedings of the 2006 ACM/IEEE Conference on Supercomputing, New York, U.S., 2006; IEEE: Piscataway, NJ, 2006.
65. Jorgensen, W. L.; Chandrasekhar, J.; Madura, J. D.; Impey, R. W.; Klein, M. L. Comparison of Simple Potential Function for Simulating Liquid Water J. Chem. Phys. 1983, 79, 926-935
66. Jorgensen, W. L.; Maxwell, D. S.; Tirado-Rives, J. Development and Testing of the OPLS All Atom Force Field on Conformational Energetics and Properties of Organic Liquids J. Am. Chem. Soc. 1996, 118, 11225-11236
67. Kaminski, G. A.; Friesner, R. A.; Tirado-Rives, J.; Jorgensen, W. L. Evaluation and Reparametrization of the OPLS-AA Force Field for Proteins via Comparison with Accurate Quantum Chemical Calculations on Peptides J. Phys. Chem. B 2001, 105, 6474-6487
68. Humphreys, D. D.; Friesner, R. A.; Berne, B. J. A Multiple-Time-Step Molecular-Dynamics Algorithm for Macromolecules J. Phys. Chem. 1994, 98, 6885-6892
69. Hoover, W. G. Canonical Dynamics-Equilibrium Phase-Space Distributions Phys. Rev. A 1985, 31, 1695-1697
70. Martyna, G. J.; Tobias, D. J.; Klein, M. L. Constant-Pressure Molecular-Dynamics Algorithms J. Chem. Phys. 1994, 101, 4177-4189
71. Essmann, U.; Perera, L.; Berkowitz, M. L.; Darden, T.; Lee, H.; Pedersen, L. G. A Smooth Particle Mesh Ewald Method J. Chem. Phys. 1995, 103, 8577-8593